Balyasny Asset Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,155
Closed -$99.4K 3331
2025
Q4
$99.4K Sell
16,155
-128,790
-89% -$934K ﹤0.01% 2963
2025
Q3
$1.05M Buy
+144,945
New +$861K ﹤0.01% 2095
2025
Q2
Sell
-862,787
Closed -$7.65M 3202
2025
Q1
$7.65M Buy
862,787
+779,405
+935% +$9.36M 0.02% 1056
2024
Q4
$1.14M Buy
+83,382
New +$1.54M ﹤0.01% 1889
2023
Q4
Sell
-290,808
Closed -$4.66M 2770
2023
Q3
$4.66M Sell
290,808
-1,155,937
-80% -$22M 0.01% 1126
2023
Q2
$33.5M Sell
1,446,745
-142,232
-9% -$3.1M 0.09% 364
2023
Q1
$36.9M Buy
+1,588,977
New +$32.3M 0.12% 309
2022
Q4
Sell
-26,245
Closed -$501K 3105
2022
Q3
$501K Sell
26,245
-8,755
-25% -$201K ﹤0.01% 2039
2022
Q2
$636K Sell
35,000
-286,067
-89% -$5.94M ﹤0.01% 1910
2022
Q1
$8.09M Buy
+321,067
New +$8.22M 0.04% 771
2021
Q4
Sell
-221,193
Closed -$7.14M 2544
2021
Q3
$7.14M Buy
+221,193
New +$7.35M 0.03% 701
2021
Q2
Sell
-213,566
Closed -$6.5M 2274
2021
Q1
$6.5M Sell
213,566
-318,529
-60% -$9.04M 0.04% 606
2020
Q4
$10.5M Buy
532,095
+335,573
+171% +$5.42M 0.07% 421
2020
Q3
$2.56M Buy
196,522
+49,941
+34% +$632K 0.02% 777
2020
Q2
$1.66M Buy
+146,581
New +$2.08M 0.02% 748
2019
Q1
Sell
-32,610
Closed -$948K 1567
2018
Q4
$948K Sell
32,610
-9,150
-22% -$329K 0.01% 916
2018
Q3
$1.92M Buy
+41,760
New +$1.86M 0.01% 993
2018
Q2
Sell
-25,355
Closed -$749K 2045
2018
Q1
$749K Buy
25,355
+3,937
+18% +$133K ﹤0.01% 1320
2017
Q4
$736K Buy
+21,418
New +$723K ﹤0.01% 1421
2017
Q1
Sell
-12,886
Closed -$215K 1738
2016
Q4
$215K Buy
+12,886
New +$233K ﹤0.01% 1273
2014
Q2
Hold
0
776
2014
Q1
Hold
0
661
2013
Q4
Hold
0
614
2013
Q3
Hold
0
697

Other funds holding MYGN